BioNxt Solutions Inc. (OTCMKTS:BNXTF) Short Interest Down 91.7% in December

BioNxt Solutions Inc. (OTCMKTS:BNXTF) was the target of a significant decline in short interest in December. As of December 15th, there was short interest totalling 4,400 shares, a decline of 91.7% from the November 30th total of 52,900 shares. Based on an average trading volume of 7,400 shares, the short-interest ratio is currently 0.6 days.

BioNxt Solutions Price Performance

Shares of BNXTF stock remained flat at $0.22 during trading hours on Thursday. BioNxt Solutions has a 12 month low of $0.11 and a 12 month high of $0.57. The company’s 50-day moving average price is $0.20 and its two-hundred day moving average price is $0.19. The firm has a market cap of $24.95 million, a PE ratio of -5.50 and a beta of 0.84.

BioNxt Solutions Company Profile

BioNxt Solutions Inc engages in generation drug formulations and delivery system in Korea, Austria, Germany, and Switzerland. The company provides drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications. It offers point-of-care diagnostic, including covid-19 PCR diagnostic kit, a covid rapid test; peri-implantitis Oral Biosensor, allows early detection of infection associated with dental implants; and H1N1 (Swine Flu) and H5N1 (Avian Flu) oral biosensors for early detection of highly pathogenic influenza a strains.